Investments

Co-Investment
Held / Exited
  • Elsan
    Co-Investment

    Elsan

    France

    Healthcare & life science
    Healthcare & life science

    Elsan is the leading private hospital operator in France. Founded in 2000, Elsan has built a network of 120 facilities in which it welcomes 2m patients per year. The Group employs 25,000 people among which 6,500 practitioners mostly working independently. It specializes in medicine, surgery, obstetrics and other medical services (dialysis, post-acute rehabilitation, imaging & radiotherapy and home hospitalization).

The Ardian team brought a deep sector knowledge, which I think allowed them not only to do a terrific job in that due diligence period, but also meant they could work very efficiently within our deal time frame.

Doug Brody KKR Capital Market

Ardian and Arsenal both want our investments to benefit society and by working together in this case we’ve reduced the time it takes to set up a clinical trial by many months, which means new drugs come to market as quickly and safely as possible.

Steve McLean Partner of Arsenal Capital

During the due diligence phase, we identified Ardian as a future shareholder capable of making a significant contribution to Emera's development. As soon as the transaction closed, we were able to define and launch value-creating initiatives with Naxicap and Ardian, particularly in terms of group structuring, external growth, digital transformation and real estate strategy, in France but also in Spain and other European countries.

Eric Baugas CEO of EMERA